基于CT影像组学的多发性骨髓瘤骨骼 生境异质性分析
CT Radiomics-Based Analysis of Skeletal Habitat Heterogeneity in Multiple Myeloma
摘要: 多发性骨髓瘤(MM)骨骼浸润的骨髓微环境空间异质性是临床诊断与疗效评估的关键难点,传统检测技术难以全面反映其病理特征。本文以CT影像组学为核心技术切入点,系统阐述MM骨骼生境异质性的病理生理基础,包括骨髓微环境的区域异质性特征、骨髓脂肪组织(BMAT)与肿瘤细胞的动态互作及微血管密度(MVD)的空间分布促瘤机制;梳理CT影像组学在多参数特征提取、机器学习骨骼分割中的技术进展,剖析肋骨、胸骨柄、胸椎等不同骨骼部位的特异性影像组学特征;明确基于灰度共生矩阵(GLCM)的细胞浸润度预测、纹理特征与骨髓纤维化的相关性等核心影像生物标志物的临床价值;总结该技术在MM早期浸润检测、治疗反应定量化评估、预后分层模型构建中的转化应用成果。同时分析当前研究面临的多模态数据融合算法优化、区域特异性生物标志物标准化等挑战,并展望未来研究方向。本文指出,CT影像组学实现了MM骨髓微环境异质性的无创定量评估,突破了传统骨髓穿刺的局限性,为MM精准诊疗提供了全新的技术手段和科学依据,其对骨髓瘤–骨骼生境互作规律的揭示也为肿瘤生态学研究提供了重要范式参考。
Abstract: The spatial heterogeneity of the bone marrow microenvironment in multiple myeloma (MM) with skeletal infiltration represents a major challenge in clinical diagnosis and treatment evaluation, as conventional detection techniques fail to comprehensively capture its pathological characteristics. This review focuses on CT radiomics as a core technological approach, systematically elucidating the pathophysiological basis of skeletal habitat heterogeneity in MM, including regional heterogeneity within the bone marrow microenvironment, dynamic interactions between bone marrow adipose tissue (BMAT) and tumor cells, and the tumor-promoting mechanisms associated with the spatial distribution of microvascular density (MVD). It outlines advances in CT radiomics for multiparametric feature extraction and machine learning-based skeletal segmentation, and analyzes site-specific radiomic features across different skeletal regions, including the ribs, sternum, and thoracic vertebrae. Key imaging biomarkers with clinical relevance are identified, such as the prediction of cellular infiltration using gray-level co-occurrence matrix (GLCM) features and the correlation between textural features and bone marrow fibrosis. The review further summarizes translational applications of this technology in early detection of MM infiltration, quantitative assessment of treatment response, and development of prognostic stratification models. Current challenges, including optimization of multimodal data fusion algorithms and standardization of region-specific biomarkers, are discussed alongside future research directions. This review indicates that CT radiomics enables non-invasive quantitative assessment of bone marrow microenvironment heterogeneity in MM, overcoming the limitations of conventional bone marrow biopsy. It provides a novel technological framework and scientific basis for precision diagnosis and treatment of MM, while also offering an important paradigm for tumor ecology research through its insights into the dynamics of myeloma-bone habitat interactions.
文章引用:梁思倩, 赵晓彬, 崔志新. 基于CT影像组学的多发性骨髓瘤骨骼 生境异质性分析[J]. 临床医学进展, 2026, 16(4): 4680-4688. https://doi.org/10.12677/acm.2026.1641740

参考文献

[1] Hiasa, M., Harada, T., Tanaka, E. and Abe, M. (2021) Pathogenesis and Treatment of Multiple Myeloma Bone Disease. Japanese Dental Science Review, 57, 164-173. [Google Scholar] [CrossRef] [PubMed]
[2] Danziger, S.A., McConnell, M., Gockley, J., et al. (2020) Bone Marrow Microenvironments That Contribute to Patient Outcomes in Newly Diagnosed Multiple Myeloma: A Cohort Study of Patients in the Total Therapy Clinical Trials. PLOS Medicine, 17, e1003323.
[3] Schinke, C., Poos, A.M., Bauer, M., John, L., Johnson, S., Deshpande, S., et al. (2022) Characterizing the Role of the Immune Microenvironment in Multiple Myeloma Progression at a Single-Cell Level. Blood Advances, 6, 5873-5883. [Google Scholar] [CrossRef] [PubMed]
[4] Jafari, A., Fairfield, H., Andersen, T.L. and Reagan, M.R. (2021) Myeloma-Bone Marrow Adipocyte Axis in Tumour Survival and Treatment Response. British Journal of Cancer, 125, 775-777. [Google Scholar] [CrossRef] [PubMed]
[5] Beider, K., Voevoda-Dimenshtein, V., Zoabi, A., Rosenberg, E., Magen, H., Ostrovsky, O., et al. (2022) CXCL13 Chemokine Is a Novel Player in Multiple Myeloma Osteolytic Microenvironment, M2 Macrophage Polarization, and Tumor Progression. Journal of Hematology & Oncology, 15, Article No. 144. [Google Scholar] [CrossRef] [PubMed]
[6] Yip, R.K.H., Er, J., Qin, L., Nguyen, Q.H., Motyer, A., Rimes, J.S., et al. (2025) Profiling the Spatial Architecture of Multiple Myeloma in Human Bone Marrow Trephine Biopsy Specimens with Spatial Transcriptomics. Blood, 146, 1837-1849. [Google Scholar] [CrossRef] [PubMed]
[7] Hagos, Y.B., Lecat, C.S.Y., Patel, D., Mikolajczak, A., Castillo, S.P., Lyon, E.J., et al. (2024) Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies. Cancer Research, 84, 493-508. [Google Scholar] [CrossRef] [PubMed]
[8] Lutz, R., Poos, A.M., Solé-Boldo, L., John, L., Wagner, J., Prokoph, N., et al. (2025) Bone Marrow Breakout Lesions Act as Key Sites for Tumor-Immune Cell Diversification in Multiple Myeloma. Science Immunology, 10, eadp6667. [Google Scholar] [CrossRef] [PubMed]
[9] Liu, J., Wang, C., Guo, W., Zeng, P., Liu, Y., Lang, N., et al. (2021) A Preliminary Study Using Spinal MRI-Based Radiomics to Predict High-Risk Cytogenetic Abnormalities in Multiple Myeloma. La radiologia medica, 126, 1226-1235. [Google Scholar] [CrossRef] [PubMed]
[10] Sachpekidis, C., Hajiyianni, M., Grözinger, M., Piller, M., Kopp-Schneider, A., Mai, E.K., et al. (2026) Validation of Novel Low-Dose CT Methods for Quantifying Bone Marrow in the Appendicular Skeleton of Patients with Multiple Myeloma: Initial Results from the [18F]FDG PET/CT Sub-Study of the Phase 3 GMMG-HD7 Trial. European Journal of Nuclear Medicine and Molecular Imaging, 53, 1509-1520. [Google Scholar] [CrossRef
[11] Sachpekidis, C., Enqvist, O., Ulén, J., Kopp-Schneider, A., Pan, L., Jauch, A., et al. (2023) Application of an Artificial Intelligence-Based Tool in [18F]FDG PET/CT for the Assessment of Bone Marrow Involvement in Multiple Myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 50, 3697-3708. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, H., Zhang, B., Chen, H., Wang, H., Qin, X., Sun, C., et al. (2025) Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow through in Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy. Advanced Science, 12, Article 2409895. [Google Scholar] [CrossRef] [PubMed]
[13] Mougiakakos, D., Bach, C., Böttcher, M., Beier, F., Röhner, L., Stoll, A., et al. (2021) The IKZF1–IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages. Cancer Immunology Research, 9, 265-278. [Google Scholar] [CrossRef] [PubMed]
[14] Kamrani, S., Naseramini, R., Khani, P., Razavi, Z.S., Afkhami, H., Atashzar, M.R., et al. (2025) Mesenchymal Stromal Cells in Bone Marrow Niche of Patients with Multiple Myeloma: A Double-Edged Sword. Cancer Cell International, 25, Article No. 117. [Google Scholar] [CrossRef] [PubMed]
[15] Iannozzi, N.T., Giuliani, N. and Storti, P. (2025) Deciphering the Bone Marrow Microenvironment’s Role in Multiple Myeloma Immunotherapy Resistance. Frontiers in Immunology, 16, Article 1613265. [Google Scholar] [CrossRef] [PubMed]
[16] de Jong, M.M.E., Kellermayer, Z., Papazian, N., Tahri, S., Hofste op Bruinink, D., Hoogenboezem, R., et al. (2021) The Multiple Myeloma Microenvironment Is Defined by an Inflammatory Stromal Cell Landscape. Nature Immunology, 22, 769-780. [Google Scholar] [CrossRef] [PubMed]
[17] Fairfield, H., Dudakovic, A., Khatib, C.M., Farrell, M., Costa, S., Falank, C., et al. (2021) Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype. Cancer Research, 81, 634-647. [Google Scholar] [CrossRef] [PubMed]
[18] Xia, J., Zhang, J., Wu, X., Du, W., Zhu, Y., Liu, X., et al. (2022) Blocking Glycine Utilization Inhibits Multiple Myeloma Progression by Disrupting Glutathione Balance. Nature Communications, 13, Article No. 4007. [Google Scholar] [CrossRef] [PubMed]
[19] Sun, J., Park, C., Guenthner, N., Gurley, S., Zhang, L., Lubben, B., et al. (2022) Tumor-Associated Macrophages in Multiple Myeloma: Advances in Biology and Therapy. Journal for ImmunoTherapy of Cancer, 10, e003975. [Google Scholar] [CrossRef] [PubMed]
[20] Urdeitx, P., Mousavi, S.J., Avril, S. and Doweidar, M.H. (2023) Computational Modeling of Multiple Myeloma Interactions with Resident Bone Marrow Cells. Computers in Biology and Medicine, 153, Article 106458. [Google Scholar] [CrossRef] [PubMed]
[21] Merz, M., Hu, Q., Merz, A.M.A., Wang, J., Hutson, N., Rondeau, C., et al. (2023) Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma. Blood Advances, 7, 718-733. [Google Scholar] [CrossRef] [PubMed]
[22] Meng, Y., Yang, Y., Hu, M., Zhang, Z. and Zhou, X. (2023) Artificial Intelligence-Based Radiomics in Bone Tumors: Technical Advances and Clinical Application. Seminars in Cancer Biology, 95, 75-87. [Google Scholar] [CrossRef] [PubMed]
[23] Prior, O., Macarro, C., Navarro, V., Monreal, C., Ligero, M., Garcia-Ruiz, A., et al. (2024) Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer. Radiology: Artificial Intelligence, 6, 12. [Google Scholar] [CrossRef] [PubMed]
[24] Hong, J.H., Jung, J., Jo, A., Nam, Y., Pak, S., Lee, S., et al. (2021) Development and Validation of a Radiomics Model for Differentiating Bone Islands and Osteoblastic Bone Metastases at Abdominal CT. Radiology, 299, 626-632. [Google Scholar] [CrossRef] [PubMed]
[25] Wennmann, M., Neher, P., Stanczyk, N., Kahl, K., Kächele, J., Weru, V., et al. (2023) Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements from Whole-Body Magnetic Resonance Imaging in Patients with Multiple Myeloma: A Retrospective Multicenter Study. Investigative Radiology, 58, 273-282. [Google Scholar] [CrossRef] [PubMed]
[26] Mann, D.C., Rutherford, M.W., Farmer, P., Eichhorn, J.M., Palot Manzil, F.F. and Wardell, C.P. (2025) Evaluating Skellytour for Automated Skeleton Segmentation from Whole-Body CT Images. Radiology: Artificial Intelligence, 7, e240050. [Google Scholar] [CrossRef] [PubMed]
[27] Hussain, M., Khan, F. and Al Hadidi, S. (2023) The Use of Bone-Modifying Agents in Multiple Myeloma. Blood Reviews, 57, Article 100999. [Google Scholar] [CrossRef] [PubMed]
[28] Leone, A., Criscuolo, M., Gullì, C., Petrosino, A., Carlo Bianco, N. and Colosimo, C. (2021) Systemic Mastocytosis Revisited with an Emphasis on Skeletal Manifestations. La radiologia medica, 126, 585-598. [Google Scholar] [CrossRef] [PubMed]
[29] Giannandrea, D., Platonova, N., Colombo, M., Mazzola, M., Citro, V., Adami, R., et al. (2022) Extracellular Vesicles Mediate the Communication between Multiple Myeloma and Bone Marrow Microenvironment in a NOTCH Dependent Way. Haematologica, 107, 2183-2194. [Google Scholar] [CrossRef] [PubMed]
[30] Bernstein, Z.S., Kim, E.B. and Raje, N. (2022) Bone Disease in Multiple Myeloma: Biologic and Clinical Implications. Cells, 11, Article 2308. [Google Scholar] [CrossRef] [PubMed]
[31] Chakraborty, R., Hillengass, J. and Lentzsch, S. (2023) How Do We Image Patients with Multiple Myeloma and Precursor States. British Journal of Haematology, 203, 536-545. [Google Scholar] [CrossRef] [PubMed]
[32] Zheng, M., Grant, F.D. and Zhuang, H. (2024) Prominent Bone Marrow Infiltration in the Appendicular Skeleton in a B-Cell Acute Lymphoblastic Leukemia Patient Demonstrated by FDG PET-MRI. Clinical Nuclear Medicine, 49, e712-e714. [Google Scholar] [CrossRef] [PubMed]
[33] Paschali, A., Panagiotidis, E., Triantafyllou, T., Palaska, V., Tsirou, K., Verrou, E., et al. (2021) A Proposed Index of Diffuse Bone Marrow [18F]-FDG Uptake and PET Skeletal Patterns Correlate with Myeloma Prognostic Markers, Plasma Cell Morphology, and Response to Therapy. European Journal of Nuclear Medicine and Molecular Imaging, 48, 1487-1497. [Google Scholar] [CrossRef] [PubMed]
[34] Desantis, V., Andriano, A., Düking, T., Hartwig, O., Ingravallo, G., Biondo, M., et al. (2025) Spatial Imaging Unlocks the Potential of Charting Multiple Myeloma and Extramedullary Disease. Journal of Hematology & Oncology, 18, Article No. 47. [Google Scholar] [CrossRef] [PubMed]
[35] de Jong, M.M.E., Fokkema, C., Papazian, N., Czeti, Á., Appelman, M.K., Vermeulen, M., et al. (2024) An IL-1β-Driven Neutrophil-Stromal Cell Axis Fosters a Baff-Rich Protumor Microenvironment in Individuals with Multiple Myeloma. Nature Immunology, 25, 820-833. [Google Scholar] [CrossRef] [PubMed]
[36] Wennmann, M., Klein, A., Bauer, F., Chmelik, J., Grözinger, M., Uhlenbrock, C., et al. (2022) Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Marrow Characterization from Whole-Body MRI: A Multicentric Feasibility Study. Investigative Radiology, 57, 752-763. [Google Scholar] [CrossRef] [PubMed]
[37] Musto, P., Engelhardt, M., Caers, J., Bolli, N., Kaiser, M., Van de Donk, N., et al. (2021) 2021 European Myeloma Network Review and Consensus Statement on Smoldering Multiple Myeloma: How to Distinguish (and Manage) Dr. Jekyll and Mr. Hyde. Haematologica, 106, 2799-2812. [Google Scholar] [CrossRef] [PubMed]
[38] Sachpekidis, C., Enqvist, O., Ulén, J., Kopp-Schneider, A., Pan, L., Mai, E.K., et al. (2024) Artificial Intelligence-Based, Volumetric Assessment of the Bone Marrow Metabolic Activity in [18F]FDG PET/CT Predicts Survival in Multiple Myeloma. European Journal of Nuclear Medicine and Molecular Imaging, 51, 2293-2307. [Google Scholar] [CrossRef] [PubMed]
[39] Roman-Trufero, M., Auner, H.W. and Edwards, C.M. (2022) Multiple Myeloma Metabolism—A Treasure Trove of Therapeutic Targets? Frontiers in Immunology, 13, Article 897862. [Google Scholar] [CrossRef] [PubMed]
[40] Werner, S., Krauss, B. and Horger, M. (2022) Dual-Energy CT-Based Bone Marrow Imaging in Multiple Myeloma: Assessment of Focal Lesions in Relation to Disease Status and MRI Findings. Academic Radiology, 29, 245-254. [Google Scholar] [CrossRef] [PubMed]
[41] Reinert, C.P., Krieg, E., Esser, M., Nikolaou, K., Bösmüller, H. and Horger, M. (2021) Role of Computed Tomography Texture Analysis Using Dual-Energy-Based Bone Marrow Imaging for Multiple Myeloma Characterization: Comparison with Histology and Established Serologic Parameters. European Radiology, 31, 2357-2367. [Google Scholar] [CrossRef] [PubMed]
[42] Pan, Q., Luo, Y., Cao, X. and Li, J. (2021) Increased Uptake of 68Ga-Pentixafor in Thymic Rebound after Chemotherapy in a Patient with Multiple Myeloma. Clinical Nuclear Medicine, 46, 90-92. [Google Scholar] [CrossRef] [PubMed]
[43] Barakat, A., Doncheva, N.T., Prado, J., Moll, L., Jensen, J.L., Díaz-delCastillo, M., et al. (2025) A Ligand-Receptor Interactome of the Bone Tumor Microenvironment in Multiple Myeloma Bone Pain. Pain, 166, 2831-2850. [Google Scholar] [CrossRef] [PubMed]